Silibinin monotherapy prevents graft infection after orthotopic liver transplantation in a patient with chronic hepatitis C

J Hepatol. 2011 Mar;54(3):591-2; author reply 592-3. doi: 10.1016/j.jhep.2010.09.009. Epub 2010 Oct 14.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / administration & dosage
  • Antiviral Agents / therapeutic use
  • End Stage Liver Disease / surgery
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / surgery*
  • Hepatitis C, Chronic / virology
  • Humans
  • Liver Transplantation* / adverse effects
  • Male
  • Middle Aged
  • Secondary Prevention
  • Silybin
  • Silymarin / administration & dosage
  • Silymarin / therapeutic use*
  • Viral Load / drug effects

Substances

  • Antiviral Agents
  • Silymarin
  • Silybin